Established in 2008, Qurient holds a leading position in the emerging biotechnology sector in South Korea. Qurient has introduced an innovative virtual biotech model, conducting research and development not only in clinical development phases but also in the early discovery research stage, known as the 'Network R&D' model. The Network R&D model aims to efficiently innovate, enabling the exploration of new scientific advancements in various therapeutic areas through an expert network. Qurient primarily focuses on creating value from early discovery to clinical proof-of-concept.